Cheng L - Search Results

1

Widespread telomere instability in prostatic lesions.

Tu L, Huda N, Grimes BR, Slee RB, Bates AM, Cheng L, Gilley D. Tu L, et al. Among authors: cheng l. Mol Carcinog. 2016 May;55(5):842-52. doi: 10.1002/mc.22326. Epub 2015 Apr 27. Mol Carcinog. 2016. PMID: 25917938

2

Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.

Yip-Schneider MT, Barnard DS, Billings SD, Cheng L, Heilman DK, Lin A, Marshall SJ, Crowell PL, Marshall MS, Sweeney CJ. Yip-Schneider MT, et al. Among authors: cheng l. Carcinogenesis. 2000 Feb;21(2):139-46. doi: 10.1093/carcin/21.2.139. Carcinogenesis. 2000. PMID: 10657949

3

Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.

Jiang J, Neubauer BL, Graff JR, Chedid M, Thomas JE, Roehm NW, Zhang S, Eckert GJ, Koch MO, Eble JN, Cheng L. Jiang J, et al. Among authors: cheng l. Am J Pathol. 2002 Feb;160(2):667-71. doi: 10.1016/S0002-9440(10)64886-9. Am J Pathol. 2002. PMID: 11839587 Free PMC article.

4

Fas and Fas ligand expression is elevated in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Jiang J, Ulbright TM, Zhang S, Eckert GJ, Kao C, Gardner TA, Koch MO, Eble JN, Cheng L. Jiang J, et al. Among authors: cheng l. Cancer. 2002 Jul 15;95(2):296-300. doi: 10.1002/cncr.10674. Cancer. 2002. PMID: 12124829 Free article.

5

High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia.

Zeng G, Hu Z, Kinch MS, Pan CX, Flockhart DA, Kao C, Gardner TA, Zhang S, Li L, Baldridge LA, Koch MO, Ulbright TM, Eble JN, Cheng L. Zeng G, et al. Among authors: cheng l. Am J Pathol. 2003 Dec;163(6):2271-6. doi: 10.1016/S0002-9440(10)63584-5. Am J Pathol. 2003. PMID: 14633601 Free PMC article.

6

PC cell-derived growth factor expression in prostatic intraepithelial neoplasia and prostatic adenocarcinoma.

Pan CX, Kinch MS, Kiener PA, Langermann S, Serrero G, Sun L, Corvera J, Sweeney CJ, Li L, Zhang S, Baldridge LA, Jones TD, Koch MO, Ulbright TM, Eble JN, Cheng L. Pan CX, et al. Among authors: cheng l. Clin Cancer Res. 2004 Feb 15;10(4):1333-7. doi: 10.1158/1078-0432.ccr-1123-03. Clin Cancer Res. 2004. PMID: 14977833

7

Loss of 14-3-3sigma in prostate cancer and its precursors.

Cheng L, Pan CX, Zhang JT, Zhang S, Kinch MS, Li L, Baldridge LA, Wade C, Hu Z, Koch MO, Ulbright TM, Eble JN. Cheng L, et al. Clin Cancer Res. 2004 May 1;10(9):3064-8. doi: 10.1158/1078-0432.ccr-03-0652. Clin Cancer Res. 2004. PMID: 15131044

8

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status.

Hong H, Kao C, Jeng MH, Eble JN, Koch MO, Gardner TA, Zhang S, Li L, Pan CX, Hu Z, MacLennan GT, Cheng L. Hong H, et al. Among authors: cheng l. Cancer. 2004 Jul 1;101(1):83-9. doi: 10.1002/cncr.20327. Cancer. 2004. PMID: 15221992 Free article.

9

Prostatic intraepithelial neoplasia: an update.

Cheng L, Paterson RF, Beck SD, Parks J. Cheng L, et al. Clin Prostate Cancer. 2004 Jun;3(1):26-30. doi: 10.3816/cgc.2004.n.009. Clin Prostate Cancer. 2004. PMID: 15279687 Review.

10

Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate.

Sweeney C, Li L, Shanmugam R, Bhat-Nakshatri P, Jayaprakasan V, Baldridge LA, Gardner T, Smith M, Nakshatri H, Cheng L. Sweeney C, et al. Among authors: cheng l. Clin Cancer Res. 2004 Aug 15;10(16):5501-7. doi: 10.1158/1078-0432.CCR-0571-03. Clin Cancer Res. 2004. PMID: 15328189

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,881 results

Search Page

Filters